Business description: Genmab A/S

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows:

- royalties (83.2%);

- income from research and development (12.4%);

- other (4.4%): primarily income from partnership agreement.

At the end of 2023, the group had a portfolio of more than 20 products in clinical development phase and 20 in preclinical development phase.

Denmark accounts for all net sales.

Number of employees: 2,286

Sales by Activity: Genmab A/S

Fiscal Period: December20192020202120222023

Biotechnology

5.37B 10.11B 8.48B 14.6B 16.47B
See all business segments

Geographical breakdown of sales: Genmab A/S

Fiscal Period: December20192020202120222023

Denmark

5.37B 10.11B 8.48B 14.6B 16.05B

United States of America

- - - - 380M

Japan

- - - - 41M
See all geographic segments

Managers: Genmab A/S

Manager TitleAgeSince
Chief Executive Officer 63 01/99/01
Director of Finance/CFO 46 01/07/01
Corporate Officer/Principal 71 01/01/01
General Counsel 63 01/02/01
See GENMAB A/S governance

Members of the board: Genmab A/S

Director TitleAgeSince
Director/Board Member 73 01/03/01
Director/Board Member 57 01/15/01
Director/Board Member 73 01/15/01
Composition of the Board of Directors

Shareholders: Genmab A/S

NameEquities%Valuation
Wellington Management Co. LLP
4.895 %
3,237,113 4.895 % 812 M kr
GENMAB A/S
4.039 %
2,670,991 4.039 % 670 M kr
600,497 0.9080 % 151 M kr
Nykredit Bank A/S (Investment Management)
0.4779 %
316,084 0.4779 % 79 M kr
Amundi Asset Management SA (Investment Management)
0.3253 %
215,139 0.3253 % 54 M kr
NameEquities%Valuation
AllianceBernstein LP
2.306 %
15,254,347 2.306 % 383 M kr
BlackRock Advisors LLC
0.7589 %
5,019,269 0.7589 % 126 M kr
Capital Research & Management Co. (International Investors)
0.6612 %
4,373,277 0.6612 % 110 M kr
Harding Loevner LP
0.4982 %
3,294,728 0.4982 % 83 M kr
Wellington Trust Co., NA
0.3526 %
2,331,814 0.3526 % 59 M kr
List of GENMAB A/S shareholders

Holdings: Genmab A/S

NameEquities%Valuation
2,670,991 4.04% 669,839,804 $

Company details: Genmab A/S

Genmab A/S

Carl Jacobsens Vej 30 Valby

2500, Copenhagen

+45 70 20 27 28

http://www.genmab.com
address Genmab A/S(GMAB)

Bio Therapeutic Drugs

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.49%+4.49%-29.10%-32.75% 17.42B
-0.20%+1.09%+38.44%+146.53% 128B
-0.58%-2.88%+46.25%+81.36% 115B
+0.44%-0.26%-10.25%+60.43% 27.85B
-0.49%-1.41%-20.02%-69.64% 20.77B
-2.32%+2.86%-19.43%-50.37% 17.03B
-2.17%+3.02%-42.18%-75.79% 15.37B
+0.38%-1.09%+45.82%+48.04% 14.62B
+1.08%-0.71%+41.56%+121.47% 13.83B
-0.41%-2.47%+271.70%+213.74% 12.3B
Average -0.23%+0.81%+32.28%+44.30% 38.26B
Weighted average by Cap. -0.30%+0.47%+33.08%+80.50%
See all sector performances